World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
79
Citations
35921
World Ranking
17360
National Ranking
47

Stephanos J. Hadziyannis publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Stephanos J. Hadziyannis sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 324 publications — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Stephanos J. Hadziyannis D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Stephanos J. Hadziyannis sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Stephanos J. Hadziyannis is affiliated with the National and Kapodistrian University of Athens in Greece. Their research primarily focuses on the fields of Medicine, with significant work in Epidemiology, Hepatology, and Hematology.

The scientist's work has concentrated on topics related to Hepatitis C virus research, Hepatitis B virus studies, liver disease diagnosis and treatment, and aspects of blood groups and transfusion.

Recent publications include the following papers:

  • Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study (2021) published in Liver International
  • Serum hepatitis B virus RNA detectability, composition and clinical significance in patients with ab initio hepatitis B e antigen negative chronic hepatitis B (2022) published in Virology Journal
  • Current practice and contrasting views on discontinuation of nucleos(t)ide analog therapy in chronic hepatitis B (2020) published in Expert Review of Gastroenterology & Hepatology
  • Early Predictors of Anemia in Patients With Hepatitis C Genotype 1 Treated With Peginterferon Alfa-2a (40KD) Plus Ribavirin (2020) published in UNC Libraries

Frequent co-authors collaborating with Hadziyannis include:

  • Emilia Hadziyannis
  • Μargarita Papatheodoridi
  • George Papatheodoridis
  • Tung-Hung Su
  • Chun-Hsun Liao

Stephanos J. Hadziyannis has published multiple articles in several academic venues, notably:

  • Liver International
  • Virology Journal
  • Expert Review of Gastroenterology & Hepatology
  • UNC Libraries

Best Publications

  • Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose.

    Hadziyannis Sj;Sette H;Morgan Tr;Balan

  • EASL Clinical Practice Guidelines: Management of chronic hepatitis B

    C.P.G.P.P. Marcellin;G. Dusheiko;F. Zoulim;R. Esteban

  • Molecular Cloning and Disease Association of Hepatitis G Virus: A Transfusion-Transmissible Agent

    Jeff Linnen;John Wages;Zhen-Yong Zhang-Keck;Kirk E. Fry

  • MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION

    W.F Carman;S Hadziyannis;M.J Mcgarvey;M.R Jacyna

  • Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B

    Patrick Marcellin;George K.K. Lau;Ferruccio Bonino;Patrizia Farci

  • Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting-Tsung Chang

  • Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years.

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting–Tsung Chang

  • Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens.

    David A. Shafritz;Daniel Shouval;Howard I. Sherman;Stefanos J. Hadziyannis

  • Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B

    Stephanos J. Hadziyannis;Nicolaos C. Tassopoulos;E. Jenny Heathcote;Ting-Tsung Chang

  • Hepatitis B virus surface antigen levels: A guide to sustained response to peginterferon alfa‐2a in HBeAg‐negative chronic hepatitis B

    Maurizia Rossana Brunetto;Francesco Moriconi;Ferruccio Bonino;George K. K. Lau

  • Early identification of HCV genotype 1 patients responding to 24 weeks peginterferon α-2a (40 kd)/ribavirin therapy†‡§

    Donald M. Jensen;Timothy R. Morgan;Patrick Marcellin;Paul J. Pockros

  • Occurrence of hepatocellular carcinoma and decompensation in Western European patients with cirrhosis type B

    Giovanna Fattovich;Giuliano Giustina;Solko W. Schalm;Stephanos Hadziyannis

  • Efficacy of long‐term lamivudine monotherapy in patients with hepatitis B e antigen–negative chronic hepatitis B

    Stephanos J. Hadziyannis;George V. Papatheodoridis;Evangelini Dimou;Andreas Laras

  • Analysis of Liver Disease, Nuclear HBcAg, Viral Replication, and Hepatitis B Virus DNA in Liver and Serum of HBcAg Vs. Anti‐HBe Positive Carriers of Hepatitis B Virus

    Stephanos J. Hadziyannis;Harvey M. Lieberman;Gerassimos G. Karvountzis;David A. Shafritz

  • Adding-on versus switching-to adefovir therapy in lamivudine-resistant HBeAg-negative chronic hepatitis B.

    Irene Rapti;Evangelini Dimou;Panayota Mitsoula;Stephanos J. Hadziyannis

  • Sustained Response of Hepatitis B e Antigen-Negative Patients 3 Years After Treatment with Peginterferon Alfa-2a

    Patrick Marcellin;Ferruccio Bonino;George K.K. Lau;Patrizia Farci

  • The long-term outcome of interferon-α treated and untreated patients with HBeAg-negative chronic hepatitis B

    George V Papatheodoridis;Emanuel Manesis;Stephanos J Hadziyannis

  • Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter study

    Giuseppe Realdi;Giovanna Fattovich;Stephanos Hadziyannis;Solko W. Schalm

  • Hepatitis B virus genotypes and virologic response in 694 patients in phase III studies of adefovir dipivoxil

    Chris Westland;William Delaney;Huiling Yang;Shan-shan Chen

  • A Dose-Ranging Study of the Efficacy and Tolerability of Entecavir in Lamivudine-refractory Chronic Hepatitis B Patients

    Ting–Tsung Chang;Robert G. Gish;Stephanos J. Hadziyannis;Janusz Cianciara

Frequent Co-Authors

George V. Papatheodoridis
George V. Papatheodoridis National and Kapodistrian University of Athens
Patrick Marcellin
Patrick Marcellin Université Paris Cité
Ferruccio Bonino
Ferruccio Bonino National Research Council (CNR)
Mario Rizzetto
Mario Rizzetto University of Turin
Seng Gee Lim
Seng Gee Lim National University of Singapore
Howard C. Thomas
Howard C. Thomas Imperial College London
William F. Carman
William F. Carman University of Glasgow
Mitchell L. Shiffman
Mitchell L. Shiffman Bon Secours Health System
George K. K. Lau
George K. K. Lau Humanity & Health
Peter Karayiannis
Peter Karayiannis University of Nicosia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you explore options for studying Medicine in the USA, consider the growing range of online nursing and healthcare degrees. For licensed nurses aiming to advance their education, there are rn to bsn online no clinicals accredited programs that remove the barrier of in-person clinical hours and offer added flexibility.

If you're looking to move into leadership or specialized practice, Doctor of Nursing Practice (DNP) programs may be of interest. Several dnp online programs allow students to graduate more quickly. For those seeking a less demanding path, some institutions offer easy dnp programs designed with student support and manageable coursework.

Entry-level healthcare careers are also expanding. For example, individuals pursuing practical nursing will find options like fast track lpn programs online, helping them earn credentials and enter the workforce faster. These online pathways offer a variety of career opportunities while balancing the demands of school and work.

Best Scientists Citing Stephanos J. Hadziyannis

Trending Scientists

Recently Published Articles